Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
48.71
+1.65 (3.51%)
At close: Nov 26, 2025, 4:00 PM EST
48.70
-0.01 (-0.02%)
After-hours: Nov 26, 2025, 7:59 PM EST
Novo Nordisk Stock Forecast
Stock Price Forecast
The 3 analysts that cover Novo Nordisk stock have a consensus rating of "Buy" and an average price target of $54.33, which forecasts a 11.54% increase in the stock price over the next year. The lowest target is $46 and the highest is $70.
Price Target: $54.33 (+11.54%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Novo Nordisk stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 1 | 3 | 4 | 4 | 3 | 4 |
| Sell | 0 | 0 | 0 | 1 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 6 | 7 | 9 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Hold Maintains $50 → $46 | Hold | Maintains | $50 → $46 | -5.56% | Nov 25, 2025 |
| HSBC | HSBC | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 24, 2025 |
| Jefferies | Jefferies | Sell Initiates n/a | Sell | Initiates | n/a | n/a | Oct 27, 2025 |
| BMO Capital | BMO Capital | Hold Maintains $50 → $55 | Hold | Maintains | $50 → $55 | +12.91% | Oct 14, 2025 |
| HSBC | HSBC | Hold → Strong Buy Upgrades $70 | Hold → Strong Buy | Upgrades | $70 | +43.71% | Oct 2, 2025 |
Financial Forecast
Revenue This Year
317.16B
from 290.40B
Increased by 9.21%
Revenue Next Year
335.06B
from 317.16B
Increased by 5.64%
EPS This Year
23.93
from 22.63
Increased by 5.73%
EPS Next Year
25.64
from 23.93
Increased by 7.16%
Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 337.7B | 376.8B | |||
| Avg | 317.2B | 335.1B | |||
| Low | 301.8B | 301.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.3% | 18.8% | |||
| Avg | 9.2% | 5.6% | |||
| Low | 3.9% | -5.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.47 | 30.11 | |||
| Avg | 23.93 | 25.64 | |||
| Low | 21.83 | 22.68 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.0% | 25.9% | |||
| Avg | 5.7% | 7.2% | |||
| Low | -3.5% | -5.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.